PEPTONIC MEDICAL Tangible Net Worth Ratio
PEPTONIC MEDICAL tangible net worth ratio. PEPTONIC MEDICAL (28L) has a Tangible Net Worth Ratio of 3.2% as of March 2026. This metric is calculated by deducting intangible assets (€47.62 Million) from net assets (€49.17 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See PEPTONIC MEDICAL balance sheet independence to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of PEPTONIC MEDICAL (2021–2025)
Tangible net worth ratio of PEPTONIC MEDICAL from 2021 to 2025. This chart shows how PEPTONIC MEDICAL's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 3.2%, reflecting net assets of €49.17 Million with intangible assets of €47.62 Million EUR. See 28L net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
PEPTONIC MEDICAL Tangible Net Worth Ratio by Year (2021–2025)
PEPTONIC MEDICAL tangible net worth ratio by year from 2021 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for PEPTONIC MEDICAL from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 28L market cap.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -27.2% | €38.24 Million | €48.66 Million | €65.92 Million | ▼ -17.9 pp |
| 2024 | -9.4% | €48.55 Million | €53.10 Million | €70.56 Million | ▼ -33.8 pp |
| 2023 | 24.4% | €75.32 Million | €56.91 Million | €106.74 Million | ▲ +30.8 pp |
| 2022 | -6.4% | €47.09 Million | €50.10 Million | €85.75 Million | ▼ -8.1 pp |
| 2021 | 1.7% | €53.12 Million | €52.21 Million | €84.60 Million | — |